NCT07075276View on ClinicalTrials.gov

Liquid Phase Concentrated Growth Factor Versus Conventional Arthrocentesis in Temporomandibular Disc Displacement

NANot yet recruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

March 1, 2026

Study Completion Date

August 1, 2026

Conditions
Temporomandibular Disorders (TMD)Internal Derangement of the Tempromandibular JointAnterior Disc Displacement
Interventions
PROCEDURE

Liquid Phase Concentrated Growth Factor

16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with injection of liquid phase concentrated growth factor

PROCEDURE

Conventional arthrocentesis

16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with conventional arthrocentesis

Trial Locations (1)

34518

Faculty of Dentistry- Horus University in Egypt, Damietta

All Listed Sponsors
lead

Horus University

OTHER